{"id":861723,"date":"2025-06-18T10:10:34","date_gmt":"2025-06-18T14:10:34","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/dexcom-unveils-new-report-on-type-2-diabetes-management-in-the-u-s-at-ada-2025\/"},"modified":"2025-06-18T10:10:34","modified_gmt":"2025-06-18T14:10:34","slug":"dexcom-unveils-new-report-on-type-2-diabetes-management-in-the-u-s-at-ada-2025","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/dexcom-unveils-new-report-on-type-2-diabetes-management-in-the-u-s-at-ada-2025\/","title":{"rendered":"Dexcom Unveils New Report on Type 2 Diabetes Management in the U.S. at ADA 2025"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }\n.bwblockalignl { margin-left: 0px; margin-right: auto }\n.bwcellpmargin { margin-bottom: 0px; margin-top: 0px }\n.bwlistdisc { list-style-type: disc }\n.bwpadl0 { padding-left: 0px }\n.bwtablemarginb { margin-bottom: 10px }\n.bwuline { text-decoration: underline }\n.bwvertalignt { vertical-align: top }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>Dexcom Unveils New Report on Type 2 Diabetes Management in the U.S. at ADA 2025<\/b><\/p>\n<ul class=\"bwlistdisc\">\n<li><i>New State of Type 2 Report in the United States reports that a majority of healthcare professionals (HCPs) surveyed believe continuous glucose monitoring will have the potential to be more impactful on the future of Type 2 diabetes care than advancements in diabetes medications.<sup>1<\/sup><\/i><\/li>\n<li><i>Dexcom Warrior Lance Bass will share first-hand experience saying \u201cBye\u201d to fingersticks* during panel at ADA.<\/i><\/li>\n<\/ul>\n<p>SAN DIEGO&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nDexCom, Inc., the global leader in glucose biosensing, today released its &#8220;Dexcom State of Type 2 Report: Access and Attitudes Across the United States&#8221; ahead of the 85<sup>th<\/sup> Scientific Sessions of the American Diabetes Association (ADA) in Chicago. The findings provide valuable insights into the perceptions around diabetes technology from more than 400 healthcare professionals and people with Type 2 diabetes across the United States.<\/p>\n<p id=\"news-body-cta\">This press release features multimedia. View the full release here: <a href=\"https:\/\/www.businesswire.com\/news\/home\/20250618841089\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20250618841089\/en\/<\/a><\/p>\n<div id=\"bwbodyimg\" style=\"width: 480px;float:left;padding-left:0px;padding-right:20px;padding-top:0px;padding-bottom:0px\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20250618841089\/en\/2501251\/4\/Dexcom_US_SOT2_News_Release_Infographic.jpg\" alt=\"New State of Type 2 Report in the United States reports that a majority of HCPs surveyed believe continuous glucose monitoring will have the potential to be more impactful on the future of Type 2 diabetes care than advancements in diabetes medications.\" \/><\/p>\n<p style=\"font-size:85%\">New State of Type 2 Report in the United States reports that a majority of HCPs surveyed believe continuous glucose monitoring will have the potential to be more impactful on the future of Type 2 diabetes care than advancements in diabetes medications.<\/p>\n<\/div>\n<p>\nDuring the conference, Dexcom will present extensive clinical data that shows the benefits of CGM for those living with Type 2 diabetes as well as new outcomes from early Stelo users.<\/p>\n<p><b>Dexcom releases new State of Type 2 Report: Access and Attitudes Across the United States<\/b><\/p>\n<p>\nEarlier this year, Dexcom announced the release of its first multi-region report, detailing access and attitudes of individuals diagnosed with Type 2 diabetes and healthcare professionals across Europe and the Middle East (EMEA). The latest State of Type 2 Report now builds on those initial findings with data collected in the U.S. Topline takeaways include:<\/p>\n<ul class=\"bwlistdisc\">\n<li><b>Tech is believed to be an effective way to manage Type 2 diabetes: <\/b>More than half (59%) of U.S. HCPs believe that better access to CGM will be the most effective way to help people with Type 2 diabetes manage their condition over the next decade.<sup>1<\/sup><\/li>\n<li><b>U.S. HCPs support CGM as \u201cstandard of care\u201d:<\/b> 96% of providers surveyed in the U.S. agree that CGM should be the standard of care for individuals using multiple daily insulin injections, and 94% agree that CGM should be the standard of care for those on basal insulin.<sup>1<\/sup><\/li>\n<li><b>U.S. HCPs unanimously support use of CGM in combination with GLP-1 medications: <\/b>100% of U.S. HCPs surveyed recommend CGM in combination with GLP-1 or SGLT2 medication because it has the best expected outcomes for patients, and 79% of providers in EMEA agreed.<sup>1<\/sup><\/li>\n<li><b>Better coverage, more education and training can improve understanding of CGM: <\/b>HCPs believe access and understanding about the usage of CGM can be improved with additional coverage and more educational support for Americans with Type 2 diabetes, as well as more training for healthcare providers. Specifically, 60% of U.S. HCPs said additional funding or budget to cover CGM could increase usage among people with Type 2 diabetes.<sup>1<\/sup><\/li>\n<\/ul>\n<p>\n\u201cThe findings of our State of Type 2 Report in the U.S. reaffirm what we\u2019ve always believed to be true: CGM is central to the future of Type 2 diabetes care,\u201d said Jake Leach, president and chief operating officer of Dexcom. \u201cTo help drive the greatest impact for patients, a continued focus on diabetes education and access to CGMs is needed \u2013 and Dexcom is committed to advancing these around the world.\u201d<\/p>\n<p>\nRead the full Dexcom State of Type 2 Report here: <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fprovider.dexcom.com%2Ffuture-type-2-diabetes-care&amp;esheet=54277896&amp;newsitemid=20250618841089&amp;lan=en-US&amp;anchor=https%3A%2F%2Fprovider.dexcom.com%2Ffuture-type-2-diabetes-care&amp;index=1&amp;md5=70b85bad01509f8cad5717a42a423501\">https:\/\/provider.dexcom.com\/future-type-2-diabetes-care<\/a><\/p>\n<p><b>Dexcom presents robust clinical data and hosts compelling presentations<\/b><\/p>\n<p>\nConference attendees will have the opportunity to hear firsthand from Grammy-nominated singer, actor, producer and Dexcom Warrior Lance Bass about how Dexcom CGM has helped him live his best life during Dexcom\u2019s product theater on Saturday, June 21.<\/p>\n<p>\nAfter being diagnosed with Latent Autoimmune Diabetes in Adults (LADA), also known as Type 1.5 diabetes, Lance has been an advocate for the diabetes community, saying \u2018Bye\u2019 to fingersticks*, guesswork and uncertainty with the help of Dexcom G7 technology. Lance will be joined by experts who will also speak about how early adoption of CGM can improve diabetes management through personalized care in addition to innovations in Dexcom technology, including new features and in-app reports.<\/p>\n<p>\nAdditionally, Dexcom will present clinical data at the conference that continues to support the benefits of its technology for people with diabetes of all ages and stages. Most notably, several studies looking at CGM use for those with Type 2 diabetes across various insulin therapies show numerous benefits \u2013 adding to an already extensive body of evidence \u2013 from reduced mortality risk among insulin-using people<sup>2<\/sup> to reduced diabetes-related distress and improved self-management<sup>3<\/sup> among non-insulin using people.<\/p>\n<p>\nIn a real-world observational study of individuals with Type 2 diabetes not using insulin, Dexcom G7 use was associated with significantly reduced diabetes-related distress and increased adherence to healthy eating plans and exercise routines, supporting CGM as a powerful tool for behavior modification.<sup>3<\/sup><\/p>\n<p><b>For a detailed overview of all Dexcom presentations at ADA this year, visit: <\/b><a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fprofessional.diabetes.org%2Fscientific-sessions&amp;esheet=54277896&amp;newsitemid=20250618841089&amp;lan=en-US&amp;anchor=https%3A%2F%2Fprofessional.diabetes.org%2Fscientific-sessions&amp;index=2&amp;md5=fd298d77561f76ac68afe566f33c75b6\"><b>https:\/\/professional.diabetes.org\/scientific-sessions<\/b><\/a><a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fprofessional.diabetes.org%2Fscientific-sessions.&amp;esheet=54277896&amp;newsitemid=20250618841089&amp;lan=en-US&amp;anchor=.&amp;index=3&amp;md5=cea02e68dfedd9c58173b3d5a9380407\">.<\/a><\/p>\n<p><b><span class=\"bwuline\">About DexCom, Inc.<\/span><\/b><\/p>\n<p>\nDexcom empowers people to take control of health through innovative biosensing technology. Founded in 1999, Dexcom has pioneered and set the standard in glucose biosensing for more than 25 years. Its technology has transformed how people manage diabetes and track their glucose, helping them feel more in control and live more confidently.<\/p>\n<p>\nDexcom. Discover what you\u2019re made of. For more information, visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.dexcom.com&amp;esheet=54277896&amp;newsitemid=20250618841089&amp;lan=en-US&amp;anchor=www.dexcom.com&amp;index=4&amp;md5=a4172f8b5bfc6a899cd0456ee4216984\">www.dexcom.com<\/a>.<\/p>\n<p>\nCategory: IR<\/p>\n<table cellspacing=\"0\" class=\"bwtablemarginb bwblockalignl\">\n<tr>\n<td class=\"bwvertalignt bwpadl0\" rowspan=\"1\" colspan=\"1\">\n<p class=\"bwcellpmargin\">\n____________________<\/p>\n<\/td>\n<\/tr>\n<\/table>\n<p><sup>*<\/sup><span class=\"bwuline\">Fingersticks required for diabetes treatment decisions if symptoms or expectations do not match readings.<\/span><\/p>\n<p>\n1 Dexcom State of Type 2 Report (US), Dexcom data on file, 2025.<sup \/>2<sup \/>Blake CL, et al. \u201cReduced Mortality Risk Associated with Dexcom rtCGM Compared to SMBG Among People with T2D on Any Insulin Therapy.\u201d Presented at ADA 2025. 3<sup \/>Crawford, MA, et al. \u201cReal-World Dexcom CGM Use in T2D NIT: Reduced Diabetes Distress and Improved Self-Care Behaviors.\u201d Presented at ADA 2025.<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250618841089r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20250618841089\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20250618841089\/en\/<\/a><\/span><\/p>\n<p><b><span class=\"bwuline\">Media Relations Contact<br \/>\n<\/span><\/b><br \/>Nadia Conard<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:mediarelations@dexcom.com\">mediarelations@dexcom.com<\/a><\/p>\n<p><b><span class=\"bwuline\">Investor Relations Contact<br \/>\n<\/span><\/b><br \/>Sean Christensen<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:sean.christensen@dexcom.com\">sean.christensen@dexcom.com<\/a><\/p>\n<p><b>KEYWORDS:<\/b> United States North America California<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Health Medical Devices Diabetes Biometrics Health Technology General Health Biotechnology<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Photo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20250618841089\/en\/2501251\/3\/Dexcom_US_SOT2_News_Release_Infographic.jpg\" alt=\"Photo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\">New State of Type 2 Report in the United States reports that a majority of HCPs surveyed believe continuous glucose monitoring will have the potential to be more impactful on the future of Type 2 diabetes care than advancements in diabetes medications.<\/font><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Photo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20250618841089\/en\/2501247\/3\/Lance_Bass_Headshot_2025_%281%29.jpg\" alt=\"Photo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\">Dexcom Warrior Lance Bass will share first-hand experience saying \u201cBye\u201d to fingersticks during panel at ADA.<\/font><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20250618841089\/en\/1474219\/3\/New_Dexcom_Logo.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Dexcom Unveils New Report on Type 2 Diabetes Management in the U.S. at ADA 2025 New State of Type 2 Report in the United States reports that a majority of healthcare professionals (HCPs) surveyed believe continuous glucose monitoring will have the potential to be more impactful on the future of Type 2 diabetes care than advancements in diabetes medications.1 Dexcom Warrior Lance Bass will share first-hand experience saying \u201cBye\u201d to fingersticks* during panel at ADA. SAN DIEGO&#8211;(BUSINESS WIRE)&#8211; DexCom, Inc., the global leader in glucose biosensing, today released its &#8220;Dexcom State of Type 2 Report: Access and Attitudes Across the United States&#8221; ahead of the 85th Scientific Sessions of the American Diabetes Association (ADA) in Chicago. The findings provide valuable &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/dexcom-unveils-new-report-on-type-2-diabetes-management-in-the-u-s-at-ada-2025\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Dexcom Unveils New Report on Type 2 Diabetes Management in the U.S. at ADA 2025&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-861723","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Dexcom Unveils New Report on Type 2 Diabetes Management in the U.S. at ADA 2025 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/dexcom-unveils-new-report-on-type-2-diabetes-management-in-the-u-s-at-ada-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Dexcom Unveils New Report on Type 2 Diabetes Management in the U.S. at ADA 2025 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Dexcom Unveils New Report on Type 2 Diabetes Management in the U.S. at ADA 2025 New State of Type 2 Report in the United States reports that a majority of healthcare professionals (HCPs) surveyed believe continuous glucose monitoring will have the potential to be more impactful on the future of Type 2 diabetes care than advancements in diabetes medications.1 Dexcom Warrior Lance Bass will share first-hand experience saying \u201cBye\u201d to fingersticks* during panel at ADA. SAN DIEGO&#8211;(BUSINESS WIRE)&#8211; DexCom, Inc., the global leader in glucose biosensing, today released its &#8220;Dexcom State of Type 2 Report: Access and Attitudes Across the United States&#8221; ahead of the 85th Scientific Sessions of the American Diabetes Association (ADA) in Chicago. The findings provide valuable &hellip; Continue reading &quot;Dexcom Unveils New Report on Type 2 Diabetes Management in the U.S. at ADA 2025&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/dexcom-unveils-new-report-on-type-2-diabetes-management-in-the-u-s-at-ada-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-06-18T14:10:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20250618841089\/en\/2501251\/4\/Dexcom_US_SOT2_News_Release_Infographic.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dexcom-unveils-new-report-on-type-2-diabetes-management-in-the-u-s-at-ada-2025\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dexcom-unveils-new-report-on-type-2-diabetes-management-in-the-u-s-at-ada-2025\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Dexcom Unveils New Report on Type 2 Diabetes Management in the U.S. at ADA 2025\",\"datePublished\":\"2025-06-18T14:10:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dexcom-unveils-new-report-on-type-2-diabetes-management-in-the-u-s-at-ada-2025\\\/\"},\"wordCount\":1095,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dexcom-unveils-new-report-on-type-2-diabetes-management-in-the-u-s-at-ada-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250618841089\\\/en\\\/2501251\\\/4\\\/Dexcom_US_SOT2_News_Release_Infographic.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dexcom-unveils-new-report-on-type-2-diabetes-management-in-the-u-s-at-ada-2025\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dexcom-unveils-new-report-on-type-2-diabetes-management-in-the-u-s-at-ada-2025\\\/\",\"name\":\"Dexcom Unveils New Report on Type 2 Diabetes Management in the U.S. at ADA 2025 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dexcom-unveils-new-report-on-type-2-diabetes-management-in-the-u-s-at-ada-2025\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dexcom-unveils-new-report-on-type-2-diabetes-management-in-the-u-s-at-ada-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250618841089\\\/en\\\/2501251\\\/4\\\/Dexcom_US_SOT2_News_Release_Infographic.jpg\",\"datePublished\":\"2025-06-18T14:10:34+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dexcom-unveils-new-report-on-type-2-diabetes-management-in-the-u-s-at-ada-2025\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dexcom-unveils-new-report-on-type-2-diabetes-management-in-the-u-s-at-ada-2025\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dexcom-unveils-new-report-on-type-2-diabetes-management-in-the-u-s-at-ada-2025\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250618841089\\\/en\\\/2501251\\\/4\\\/Dexcom_US_SOT2_News_Release_Infographic.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250618841089\\\/en\\\/2501251\\\/4\\\/Dexcom_US_SOT2_News_Release_Infographic.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dexcom-unveils-new-report-on-type-2-diabetes-management-in-the-u-s-at-ada-2025\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Dexcom Unveils New Report on Type 2 Diabetes Management in the U.S. at ADA 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Dexcom Unveils New Report on Type 2 Diabetes Management in the U.S. at ADA 2025 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/dexcom-unveils-new-report-on-type-2-diabetes-management-in-the-u-s-at-ada-2025\/","og_locale":"en_US","og_type":"article","og_title":"Dexcom Unveils New Report on Type 2 Diabetes Management in the U.S. at ADA 2025 - Market Newsdesk","og_description":"Dexcom Unveils New Report on Type 2 Diabetes Management in the U.S. at ADA 2025 New State of Type 2 Report in the United States reports that a majority of healthcare professionals (HCPs) surveyed believe continuous glucose monitoring will have the potential to be more impactful on the future of Type 2 diabetes care than advancements in diabetes medications.1 Dexcom Warrior Lance Bass will share first-hand experience saying \u201cBye\u201d to fingersticks* during panel at ADA. SAN DIEGO&#8211;(BUSINESS WIRE)&#8211; DexCom, Inc., the global leader in glucose biosensing, today released its &#8220;Dexcom State of Type 2 Report: Access and Attitudes Across the United States&#8221; ahead of the 85th Scientific Sessions of the American Diabetes Association (ADA) in Chicago. The findings provide valuable &hellip; Continue reading \"Dexcom Unveils New Report on Type 2 Diabetes Management in the U.S. at ADA 2025\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/dexcom-unveils-new-report-on-type-2-diabetes-management-in-the-u-s-at-ada-2025\/","og_site_name":"Market Newsdesk","article_published_time":"2025-06-18T14:10:34+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20250618841089\/en\/2501251\/4\/Dexcom_US_SOT2_News_Release_Infographic.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dexcom-unveils-new-report-on-type-2-diabetes-management-in-the-u-s-at-ada-2025\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dexcom-unveils-new-report-on-type-2-diabetes-management-in-the-u-s-at-ada-2025\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Dexcom Unveils New Report on Type 2 Diabetes Management in the U.S. at ADA 2025","datePublished":"2025-06-18T14:10:34+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dexcom-unveils-new-report-on-type-2-diabetes-management-in-the-u-s-at-ada-2025\/"},"wordCount":1095,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dexcom-unveils-new-report-on-type-2-diabetes-management-in-the-u-s-at-ada-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250618841089\/en\/2501251\/4\/Dexcom_US_SOT2_News_Release_Infographic.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dexcom-unveils-new-report-on-type-2-diabetes-management-in-the-u-s-at-ada-2025\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/dexcom-unveils-new-report-on-type-2-diabetes-management-in-the-u-s-at-ada-2025\/","name":"Dexcom Unveils New Report on Type 2 Diabetes Management in the U.S. at ADA 2025 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dexcom-unveils-new-report-on-type-2-diabetes-management-in-the-u-s-at-ada-2025\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dexcom-unveils-new-report-on-type-2-diabetes-management-in-the-u-s-at-ada-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250618841089\/en\/2501251\/4\/Dexcom_US_SOT2_News_Release_Infographic.jpg","datePublished":"2025-06-18T14:10:34+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dexcom-unveils-new-report-on-type-2-diabetes-management-in-the-u-s-at-ada-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/dexcom-unveils-new-report-on-type-2-diabetes-management-in-the-u-s-at-ada-2025\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dexcom-unveils-new-report-on-type-2-diabetes-management-in-the-u-s-at-ada-2025\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20250618841089\/en\/2501251\/4\/Dexcom_US_SOT2_News_Release_Infographic.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20250618841089\/en\/2501251\/4\/Dexcom_US_SOT2_News_Release_Infographic.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dexcom-unveils-new-report-on-type-2-diabetes-management-in-the-u-s-at-ada-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Dexcom Unveils New Report on Type 2 Diabetes Management in the U.S. at ADA 2025"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/861723","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=861723"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/861723\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=861723"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=861723"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=861723"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}